Flavahan Nicholas A
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Ross Research Building R370, 720 Rutland Avenue, Baltimore, MD 21205, USA.
Rheum Dis Clin North Am. 2008 Feb;34(1):81-7; vii. doi: 10.1016/j.rdc.2007.12.005.
Because of the role of the RhoA/Rho kinase (ROCK) pathway in regulating numerous pathologic processes including vasoconstriction, vascular remodeling, and fibrosis, ROCK inhibitors may be especially beneficial in treating Raynaud's phenomenon and scleroderma.
由于RhoA/Rho激酶(ROCK)通路在调节包括血管收缩、血管重塑和纤维化在内的众多病理过程中发挥作用,ROCK抑制剂在治疗雷诺现象和硬皮病方面可能特别有益。